Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,997Revenue $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M3,997EPS $--Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book1.010-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %1.5PEG1.2ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M20.6ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with IYH

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

IYH is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


IYH: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Bunka, ChristopherDirector, Senior Officer 2015-05-22Buy20,000$0.1888261.11 view
Bunka, ChristopherDirector, Senior Officer 2015-05-22Buy10,000$0.1793458.82 view
Bunka, ChristopherDirector, Senior Officer 2015-05-22Buy10,000$0.1793458.82 view
Pommier, PaulDirector 2015-05-22Buy4,700$1.3811425.36 view
Pommier, PaulDirector 2015-05-22Buy20,300$1.411260.71 view
Smith, MarkDirector, Senior Officer 2015-05-22Buy5,000$0.6524369.23 view
MERCER, JOHN WILLIAMDirector, Senior Officer 2015-05-22Buy100,000$0.07227114.29 view
Aggarwal, SalilSenior Officer 2015-05-22Sell10,000$1.649598.17 view
Wilson, JamesDirector or Senior Officer of 10% Security Holder 2015-05-22Buy6,700$8.151851.53 view
Shareck, AndrDirector 2015-05-22Buy200,000$0.03530066.67 view

Press Releases about IYH :

    Quarterly/Annual Reports about IYH:

      News about IYH:

      Articles On GuruFocus.com
      No related article found.

      More From Other Websites
      Where Do Dividend Opportunities Lie Today? May 21 2015
      Innovators to Support Healthcare Sector, ETFs’ Growth May 20 2015
      Blue Ridge Capital Reduces Position in Actavis May 12 2015
      Mylan’s Share Price Declines 3% on 1Q15 Earnings May 12 2015
      Mylan’s Pursuit of Perrigo Could Yield Massive Synergies May 11 2015
      The Many Reasons Mylan Is So Keen to Acquire Perrigo May 11 2015
      What Investors Can Expect from Pfizer in 2015 May 11 2015
      Teva’s Shares Dip over 1Q15 Earnings May 11 2015
      Key Factors That Impact Johnson & Johnson’s Forward Valuation May 11 2015
      Pfizer Stock Dips over 1Q15 Forward Valuation Concerns May 09 2015
      Why Teva’s Generic Medicines Profitability Improved in 1Q15 May 08 2015
      Why Teva’s Specialty Medicines Performance Declined in 1Q15 May 08 2015
      Where Mylan Saw 1Q15 Revenue Increase May 08 2015
      Mylan Reports 1Q15 Earnings Per Share Growth of 6% May 08 2015
      Pfizer Revenues Hit by Lost Exclusivity in 1Q15 May 08 2015
      Pfizer’s Exposure to Overseas Markets Soaks 1Q15 Revenues May 08 2015
      Why Teva’s 1Q15 Revenues Declined Marginally May 06 2015
      Teva’s Adjusted Earnings Per Share Improved 11% in 1Q15 May 06 2015
      Shares Rise 2% after Novartis Posts 1Q15 Earnings May 06 2015
      Is Novartis an Up-and-Coming Oncology Powerhouse? May 05 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK